Correlation Between Exagen and Trinity Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Exagen and Trinity Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exagen and Trinity Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Exagen Inc and Trinity Biotech plc, you can compare the effects of market volatilities on Exagen and Trinity Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exagen with a short position of Trinity Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exagen and Trinity Biotech.

Diversification Opportunities for Exagen and Trinity Biotech

-0.57
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Exagen and Trinity is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Exagen Inc and Trinity Biotech plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Trinity Biotech plc and Exagen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exagen Inc are associated (or correlated) with Trinity Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Trinity Biotech plc has no effect on the direction of Exagen i.e., Exagen and Trinity Biotech go up and down completely randomly.

Pair Corralation between Exagen and Trinity Biotech

Considering the 90-day investment horizon Exagen Inc is expected to generate 0.77 times more return on investment than Trinity Biotech. However, Exagen Inc is 1.3 times less risky than Trinity Biotech. It trades about 0.04 of its potential returns per unit of risk. Trinity Biotech plc is currently generating about -0.03 per unit of risk. If you would invest  266.00  in Exagen Inc on September 3, 2024 and sell it today you would earn a total of  153.00  from holding Exagen Inc or generate 57.52% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Exagen Inc  vs.  Trinity Biotech plc

 Performance 
       Timeline  
Exagen Inc 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Exagen Inc are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, Exagen displayed solid returns over the last few months and may actually be approaching a breakup point.
Trinity Biotech plc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Trinity Biotech plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's forward indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Exagen and Trinity Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Exagen and Trinity Biotech

The main advantage of trading using opposite Exagen and Trinity Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exagen position performs unexpectedly, Trinity Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Trinity Biotech will offset losses from the drop in Trinity Biotech's long position.
The idea behind Exagen Inc and Trinity Biotech plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Commodity Directory
Find actively traded commodities issued by global exchanges
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon